Deconstructing the molecular mechanisms of cell cycle control in a mouse adrenocortical cell line: Roles of ACTH

Microscopy Research and Technique

Volumn 61, Issue 3, 2003, Pages 268-274

  Rocha, Kátia M ^a   Forti, Fábio L ^a   Lepique, Ana P ^a   Armelin, Hugo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AKT PKB; c myc; Cyclin; Cyclin dependent kinase; ERK; FGF2; Ki ras; PKA

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; CELL SIGNALING; CELLS; CHEMICAL ACTIVATION;

ADRENOCORTICAL CELLS; AKT/PKB; C-MYC; CELL-CYCLE CONTROLS; CYCLIN-DEPENDENT KINASE; CYCLINS; ERK; FGF2; KI-RAS; PKA;

PROTEINS;

CD30 ANTIGEN; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; DNA; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PROTEIN C FOS; PROTEIN P27; RAS PROTEIN; RETINOBLASTOMA PROTEIN;

ADRENAL CORTEX CELL; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; GROWTH REGULATION; HORMONE ACTION; MITOGENESIS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM;

EID: 0038485674     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10336     Document Type: Article

References (47)

1. Almendral JM, Sommer D, Macdonald-Bravo H, Burckhardt J, Perera J, Bravo R. 1988. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 8:2140-2148.
2. Angel P, Karin M. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochem Biophys Acta 1072:129-157.
3. Armelin HA, Lotfi CFP, Lepique AP. 1996. Regulation of growth by ACTH in the Y-1 of mouse adrenocortical cells. Endocr Res 22:373-383.
4. Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke (2001) ACTH-receptor expression, regulation and role in adrenocortical tumor formation. Eur J Endocrinol 144:199-206.
5. Bicknell AB, Lomthaisong K, Woods RJ, Hutchinson EG, Bennett HP, Gladwell RT, Lowry PJ. 2001. Characterization ofa serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 105:903-912.
6. de Rooij J, Bos, JL. 1997. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14:623-625.
7. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
8. Forti FL, Armelin HA. 2000. ACTH inhibits A Ras-dependent anti-apoptotic and mitogenic pathway in mouse Y1 adrenocortical cells. Endocr Res 26:911-914.
9. Kip1 induction in mouse Y1 adrenocortical tumor cells dependent on both PKA activation and Akt/PKB inactivation. Biochemistry 41:10133-10140.
10. George DL, Francke U. 1980. Homogeneously staining chromosome regions and double minutes in a mouse adrenocortical tumor cell line. Cytogenet Cell Genet 28:217-226.
11. Grandori C, Cowley SM, James LP, Eisenman RN. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16:653-699.
12. Heisler S, Tallerico-Melnyk T, Yip C, Schimmer BP. 1989. Y-1 adrenocortical tumor cells contain atrial natriuretic peptide receptors which regulate cyclic nucleotide metabolism and steroidogenesis. Endocrinology 125:2235-2243.
13. Herschman HR. 1991. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60:281-319.
14. Hornsby PJ. 1985. Regulation of adrenocortical cell proliferation in culture. Endocr Res 10:259-281.
15. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein JB. 1993. Overexpression of cyclin DI in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457.
16. Kauffman-Zeh A, Rodriguez-Viciana P, Ulrich, E, Gilbert C, Coffer P, Downward J, Evan G. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI3K and PKB. Nature 385:544-548.
17. Kimura E, Armelin HA. 1988a. Growth control in mouse Y-1 adrenocortical tumor cells: role of c-Ki-ras amplification and effects of ACTH. Arch Biol Med Exp 21:435-441.
18. Kimura E, Armelin HA. 1988b. Role of proto-oncogene c-Ki-ras amplification and overexpression in the malignancy of Y-1 adrenocortical tumor cells. Braz J Med Biol Res 21:189-201.
19. Kimura E, Armelin HA. 1990. Phorbol ester mimics ACTH action in adrenocortical cells stimulating steroidogenesis, blocking cell cycle, changing shape and inducing c-fos proto-oncogene expression. J Biol Chem 265:3518-3521.
20. Kimura E, Sonobe MH, Armelin MCS, Armelin HA. 1993. Induction of FOS and JUN proteins by adrenocorticotropin and phorbol ester but not by 3′,5′-cyclic adenosin monophosphate derivatives. Mol Endocrinol 7:1463-1471.
21. Kovary K, Bravo R. 1991a. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts-in vivo and in vitro associations. Mol Cell Biol 11:2451-2459.
22. Kovary K, Bravo R. 1991b. The Jun and Fos protein families are both required for cell-cycle progression in fibroblasts. Mol Cell Biol 11:4466-4472.
23. Lepique AP, Forti FL, Moraes MS, Armelin HA. 2000. Signal transduction in G0/G1-arrested mouse Y1 adrenocortical cells stimulated by ACTH and FGF2. Endocr Res 26:825-832.
24. Liebmann C. 2001. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal 13:777-785.
25. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI. (1995). A modified estrogen receptor ligand-binding domain as an improved switch for the regulation ofheterologous proteins. Nucleic Acids Res 23:1686-90
26. Lotfi CFP, Todorovic Z, Armelin HA, Schimmer BP. 1997. Unmasking a growth promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells. J Biol Chem 272:29886-29890.
27. Lotfi CF, Costa ET, Schwindt TT, Armelin HA. 2000. Role of ERK/MAP kinase in mitogenic interaction between ACTH and FGF2 in mouse Y1 adrenocortical tumor cells. Endocr Res 26:873-877.
28. Malumbres M, Pellicer A. 1998. RAS pathways to cell cycle control and cell transformation. Front Biosci. 3:d887-912.
29. New MI. 1998. Diagnosis and management of congenital adrenal hyperplasia. Annu Rev Med 49:311-328.
30. Pavletich NP. 1999. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287:821-828.
31. Quelle DE, Ashmun RA, Shurtleff SE, Kato JY, Barsagi D, Roussel M, Sherr CJ. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559-1571.
32. Rae PA, Gutmann NS, Tsao J, Schimmer BP. 1979. Mutations in cAMP dependet protein kinase and ACTH sensitive adenylate cyclase affect adrenal steroidogenesis. Proc Natl Acad Sci USA 76:1869-1900.
33. Resnitzky D, Gossen M, Bujard H, Reed SI. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679.
34. Schimmer BP. 1979. Adrenocortical Y1 cells. Methods Enzymol 58:570-574.
35. Schimmer BP. 1981. The adrenocortical tumor cell line, Y-1. In: Sato, G editor. Functionally differentiated cell lines. New York: Liss. p 61-92.
36. Schimmer BP, Parker KL. 1992. Promoter elements of the mouse 21-hydroxylase (Cyp-21) gene involved in cell-selective and cAMP-dependent gene expression. J Steroid Biochem Mol Biol 43:937-950.
37. Schwab M, Alitalo K, Varmus H, Bishop J, George D. 1983. A cellular oncogene (c-Ki-ras) is amplified, overexpressed and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature 303:497-501.
38. Sherr CJ. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
39. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
40. Stocco DM. 2000. Intramitochondrial cholesterol transfer. Biochim Biophys Acta 1486:184-197.
41. Tong W, Pollard JW. 2001. Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice. Mol Cell Biol 21:1319-1328.
42. Trumpp A, Rafaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414:768-773.
43. Vidal A, Koff A. 2000. Cell-cycle inhibitors: three families united by a common cause. Gene 247:1-15.
44. Wang TC, Cardiff RD, Zuckerberg L, Lees E, Arnold A, Schmidt EV. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
45. Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I, Leder P. 1999. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 96:689-700.
46. Yasumura Y, Buonassissi Y, Sato G. 1966. Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype. Cancer Res 26:529-535.
47. Yu Q, Geng Y, Sicinski P. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.